TY - JOUR
T1 - Assessment of the Florida Pharmacist Self-Care Consultant Law using patient profile and prescription audit methods
AU - Eng, H. J.
AU - McCormick, W. C.
AU - Monsanto, H. A.
AU - Saint-Pierre, J.
PY - 1990
Y1 - 1990
N2 - This article examines pharmacist and physician prescribing patterns during the first two years of the Florida Pharmacist Self-Care Consultant Law. Nineteen pharmacies were audited. The mandatory patient profiles were audited for a two-year period, and the prescription files were audited for a five-year period. For the nine pharmacies maintaining patient profiles, the prescribing activities of the pharmacists almost double from the first year to the second year. However, these prescriptions made up a very small portion of the total. Pharmacist prescribing appeared to be limited to three primary drug categories: topical pediculicides (lindane shampoo), oral analgesics, and otic analgesics; these comprised 82 percent of all pharmacist-generated prescriptions.
AB - This article examines pharmacist and physician prescribing patterns during the first two years of the Florida Pharmacist Self-Care Consultant Law. Nineteen pharmacies were audited. The mandatory patient profiles were audited for a two-year period, and the prescription files were audited for a five-year period. For the nine pharmacies maintaining patient profiles, the prescribing activities of the pharmacists almost double from the first year to the second year. However, these prescriptions made up a very small portion of the total. Pharmacist prescribing appeared to be limited to three primary drug categories: topical pediculicides (lindane shampoo), oral analgesics, and otic analgesics; these comprised 82 percent of all pharmacist-generated prescriptions.
UR - http://www.scopus.com/inward/record.url?scp=0025040019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025040019&partnerID=8YFLogxK
U2 - 10.1177/106002809002401004
DO - 10.1177/106002809002401004
M3 - Article
C2 - 2244406
AN - SCOPUS:0025040019
SN - 1042-9611
VL - 24
SP - 931
EP - 935
JO - DICP, Annals of Pharmacotherapy
JF - DICP, Annals of Pharmacotherapy
IS - 10
ER -